Cytek Biosciences, Inc. Common Stock
Symbol: CTKB (NASDAQ)
Company Description:
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
- Today's Open: $2.65
- Today's High: $2.705
- Today's Low: $2.595
- Today's Volume: 931.10K
- Yesterday Close: $2.67
- Yesterday High: $2.68
- Yesterday Low: $2.52
- Yesterday Volume: 1.44M
- Last Min Volume: 8.90K
- Last Min High: $2.685
- Last Min Low: $2.685
- Last Min VWAP: $2.685
- Name: Cytek Biosciences, Inc. Common Stock
- Website: https://www.cytekbio.com
- Listed Date: 2021-07-23
- Location: FREMONT, CA
- Market Status: Active
- CIK Number: 0001831915
- SIC Code: 3826
- SIC description: LABORATORY ANALYTICAL INSTRUMENTS
- Market Cap: $382.51M
- Round Lot: 100
- Outstanding Shares: 126.66M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-08 | 10-Q | View |
2025-05-08 | 8-K | View |
2025-04-30 | SCHEDULE 13G/A | View |
2025-04-28 | ARS | View |
2025-04-28 | DEFA14A | View |
2025-04-28 | DEF 14A | View |
2025-03-12 | 4 | View |
2025-03-12 | 4 | View |
2025-03-12 | 4 | View |
2025-03-12 | 4 | View |
2025-03-12 | 4 | View |
2025-03-06 | 4 | View |
2025-03-06 | 4 | View |
2025-03-06 | 4 | View |
2025-03-06 | 4 | View |
2025-03-06 | 4 | View |
2025-02-28 | S-8 | View |
2025-02-28 | 10-K | View |
2025-02-27 | 8-K | View |